Skip to main content
. 2019 Jan 8;10(1):e01245-18. doi: 10.1128/mBio.01245-18

TABLE 2.

Evolutionary rates (10−3 codon substitutions/site/year) in the V1-C3 env regions determined using a strict clock hierarchical phylogenetic modela

Genetic
region
All
individualsc
CD4% stratification
CD4% decline rate
CD4% level and the combined coefficientb
Fast
progressorsc
Slow
progressorsc
Bayes factord Fast
progressorsc
Slow
progressorsc
Bayes factord
V1-C3 23.5 (20.3-26.6) 24.7 (20.1-29.6) 21.9 (19.1-24.9) 0.3 28.6 (24.2-33.5) 14.9 (12.2-17.6) 20.3
V1V2 29.5 (25.1-34.2)a 30.1 (24.6-36.0) 28.8 (23.7-34.0) 0.3 35.4 (28.9-42.2) 19.6 (14.8-24.7) 11.8
C2 18.0 (15.2-20.7)a 18.6 (15.3-21.9) 16.7 (13.9-19.5) 0.3 21.5 (17.6-25.7) 12.0 (9.2-15.2) 28.4
V3 21.2 (17.0-25.7)a 21.6 (16.5-26.8) 20.8 (15.7-25.9) 0.3 24.1 (18.0-30.6) 16.5 (11.0-22.2) 2.4
C3 26.6 (22.6-31.1)a 27.0 (22.0-32.4) 26.0 (21.6-30.6) 0.2 30.4 (24.3-27.0) 20.2 (15.2-25.8) 6.1
a

P values for Wilcoxon signed rank tests for comparisons of rates between regions were as follows: for V1V2 versus C2, <0.001; for V1V2 versus V3, 0.002; for V1V2 versus C3, 1; for C2 versus V3, 0.005; for C2 versus C3, <0.001; for V3 versus C3, <0.001.

b

The combined coefficient values represent a combination of CD4% decline rate and CD4% level.

c

Data correspond to 10−3 codon substitutions per site per year (95% highest posterior density interval).

d

Bayes factor (BF) support for association between codon substitution rate and disease progression (faster versus slower progressors). BF >3 was considered evidence of a significant association.